Barrington lowered the firm’s price target on Concentrix (CNXC) to $38 from $62 and keeps an Outperform rating on the shares. following the fiscal Q1 report. The firm believes the company gained market share and wallet share in the quarter. The analyst cites increased execution risk given the “slippage” reported in the quarter for the target cut.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNXC: